TA1/LAT-1/CD98 light chain and system L activity, but not 4F2/CD98 heavy chain, respond to arginine availability in rat hepatic cells - Loss of response in tumor cells

被引:46
|
作者
Campbell, WA
Sah, DE
Medina, MM
Albina, JE
Coleman, WB
Thompson, NL
机构
[1] Brown Univ, Rhode Isl Hosp, Div Med Oncol, Sch Med, Providence, RI 02903 USA
[2] Brown Univ, Rhode Isl Hosp, Dept Surg, Sch Med, Providence, RI 02903 USA
[3] Grad Program Pathobiol, Providence, RI 02903 USA
[4] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1074/jbc.275.8.5347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor associated gene-1/L amino acid transporter-1 (TA1/LAT-1) was recently identified as a light chain of the CD98 amino acid transporter and cellular activation marker. Our previous studies with primary rat hepatocyte cultures demonstrated that TA1 RNA levels were responsive to media amino acid concentrations, suggesting adaptive regulation, High level TA1 expression associated with transformed cells also suggested a role in tumor progression. The present study examined the relationship of TA1/CD98 expression, adaptive response, and associated amino acid transport to neoplastic transformation using a panel of well characterized rat hepatic cell lines. We found 1) increased expression of TA1 in response to amino acid depletion, specific for arginine but not glutamine; 2) loss of TA1 response to arginine in gamma-glutamyl transpeptidase-positive transformed and tumorigenic cells; 3) no appreciable response of 4F2/CD98 heavy chain to arginine levels; and 4) correlation of system L amino acid transport activity in response to arginine with changes in TA1/LAT-1 mRNA but not total immunoreacting protein. Our results suggest this CD98 Light chain may act as an environmental sensor, responding to amino acid availability and that its regulation is complex. We hypothesize that altered TA1 expression is an early event in hepatocarcinogenesis giving neoplastic cells a growth or survival advantage, particularly under conditions of limited amino acid availability.
引用
收藏
页码:5347 / 5354
页数:8
相关论文
共 22 条
  • [1] Molecular cloning of the rat TA1/LAT-1/CD98 light chain gene promoter
    Diah, SK
    Padbury, JF
    Campbell, WA
    Britt, D
    Thompson, NL
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2001, 1518 (03): : 267 - 270
  • [2] Transcriptional regulation of the LAT-1/CD98 light chain
    Padbury, JF
    Diah, SK
    McGonnigal, B
    Miller, C
    Fugere, C
    Kuzniar, M
    Thompson, NL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 318 (02) : 529 - 534
  • [3] Light chain of CD98 is identified as E16/TA1 protein
    Mannion, Brian A.
    Kolesnikova, Tatiana V.
    Lin, Sue Hwa
    Wang, Shuo
    Thompson, Nancy L.
    Hemler, Martin E.
    Journal of Biological Chemistry, 1998, 273 (50):
  • [4] The light chain of CD98 is identified as E16/TA1 protein
    Mannion, BA
    Kolesnikova, TV
    Lin, SH
    Wang, S
    Thompson, NL
    Hemler, ME
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (50) : 33127 - 33129
  • [5] Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma
    Kaira, Kyoichi
    Oriuchi, Noboru
    Imai, Hisao
    Shimizu, Kimihiro
    Yanagitani, Noriko
    Sunaga, Noriaki
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Kanai, Yoshikatsu
    Nakajima, Takashi
    Mori, Masatomo
    LUNG CANCER, 2009, 66 (01) : 120 - 126
  • [6] Evaluation of CD98 light chain-LAT1 as a potential marker of cancer stem-like cells in glioblastoma
    Wang, Xiang
    Chen, Jinxiu
    Liu, Xiang-hao
    Zeng, Xiang-yi
    Long, Qiang-you
    Liu, Yan-hui
    Mao, Qing
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2022, 1869 (09):
  • [7] Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung
    Kaira, Kyoichi
    Oriuchi, Noboru
    Imai, Hisao
    Shimizu, Kimihiro
    Yanagitani, Noriko
    Sunaga, Noriaki
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Kanai, Yoshikatsu
    Endou, Hitoshi
    Nakajima, Takashi
    Mori, Masatomo
    CANCER SCIENCE, 2009, 100 (02) : 249 - 254
  • [8] Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)
    Kanai, Y
    Segawa, H
    Miyamoto, K
    Uchino, H
    Takeda, E
    Endou, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 23629 - 23632
  • [9] 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer
    Nakamura, E
    Sato, M
    Yang, HL
    Miyagawa, F
    Harasaki, M
    Tomita, K
    Matsuoka, S
    Noma, A
    Iwai, K
    Minato, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) : 3009 - 3016
  • [10] TA1 and amino acid transport respond to arginine availability in rat hepatic cells: Loss of response in tumor cells.
    Campbell, W
    Sah, DE
    Coleman, WB
    Thompson, NL
    FASEB JOURNAL, 2000, 14 (04): : A447 - A447